• SIGN IN
  • GET HELP
  •  

    Webinar Details


    Event Type

    Live Online

    Date

    Wednesday, October 13, 2021

    Time

    8:00 PM - 9:15 PM ET

    Location

    PharmCon Webinar Studio (freeCE.com)

    Credits

    1.25 Contact Hour(s)

    Target Audience

    Pharmacist, Pharmacy Technician

    Cost

    $30.00

    • Overview

      Buprenorphine is perhaps the most highly misunderstood medication of our time, or at least within the pain management pharmacological treatment options. Being utilized within the indications of pain management and opioid use disorder (opioid addiction) certainly propels it to the top of any polarized discussions to say the least. So how does one navigate through the pharma-sea of opinions? Join us for a dynamic discussion on the complicated simplicities of buprenorphine pharmacology including partial mu opioid agonism, mu opioid receptor affinity, half-life related dosage selections, CYP-450 metabolism and respective interactions, maximum dosage recommendations, morphine milligram equivalent (MME) calculations, and the infamous respiratory depression relative ceiling effects. Dispelling every rumor, one pharmacological principal at a time, helping you help your patients every day. 


      Handouts

      Slide Document 21227L08_2pp.pdf
      Slide Document 21227L08_6pp.pdf





      Financial Support By

      PharmCon
    • Pharmacist

      Differentiate buprenorphine prescription products by FDA approved indications for pain management and opioid use disorder.
      Describe buprenorphine’s atypical prescription opioid mechanism of action as a partial mu opioid agonist with greater than average mu opioid receptor affinity and relative respiratory depression ceiling effect.
      Recall buprenorphine’s pharmacological properties relevant to patient care including CYP-3A4 interactions, long half-life, maximum recommended dosage, and morphine milligram equivalency.

      Pharmacy Technician

      Differentiate buprenorphine prescription products by FDA approved indications for pain management and opioid use disorder.
      Describe buprenorphine’s atypical prescription opioid mechanism of action as a partial mu opioid agonist with greater than average mu opioid receptor affinity and relative respiratory depression ceiling effect.
      Recall buprenorphine’s pharmacological properties relevant to patient care including CYP-3A4 interactions, long half-life, maximum recommended dosage, and morphine milligram equivalency.
    • Repeat Presentation

      This presentation was last given on 10/13/2021 8:00 PM

      Future Airings

      Date Time
      Monday, November 8, 2021 10:30 AM View
      Tuesday, December 7, 2021 10:30 AM View

    • Activity Type

      Knowledge

      CE Broker

      20-874350

      Universal Activity Number

      Pharmacist 0798-0000-21-227-L08-P

      Pharmacy Technician 0798-0000-21-227-L08-T

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, attendees must respond to all randomly-generated participation checks and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


    HARDWARE REQUIREMENTS
    Windows 8.1
    Windows 10
    Apple Mac OS X 10.13 or higher
    iOS 10+
    Android 4.3+


    SOFTWARE REQUIREMENTS
    Google Chrome
    Mozilla Firefox

    Log in locally; do not log in using a VPN, cloud server, remote desktop, etc.


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon. Through this notice, PharmCon. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




    Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.